Frank Wesley Rockhold
Professor of Biostatistics & Bioinformatics

Prior to joining the Duke faculty, Frank’s career included senior research positions at Lilly Research Laboratories, Merck Research Laboratories and GlaxoSmithKline, where he recently retired as Senior Vice President of Global Clinical Safety and Pharmacovigilance.   He has been a leader in the scientific community in promoting data disclosure and transparency in clinical research.  Frank served for 9 years on the board of directors of the non-profit CDISC, most recently as Chairman and is past president of the Society for Clinical Trials. He is a member of the PCORI Advisory Panel on Clinical Trials and on the board of the Frontier Science and Technology Research Foundation.  Frank has more than 75 publications in major scientific journals across a wide variety of topics and has held faculty appointments at five other universities, including a current post as Affiliate Professor of Biostatistics at Virginia Commonwealth University Medical Center.  He is also currently Managing Partner of HunterRockhold, Inc., which provides strategic consulting to Industry, Government, and Academia in the areas of clinical trials, safety and pharmacovigilance, data disclosure and transparency.   He holds a BA in Statistics from The University of Connecticut, an ScM in Biostatistics from The Johns Hopkins University, and a PhD in Biostatistics from the Medical College of Virginia.   Frank is a Fellow of both the American Statistical Association and the Society for Clinical Trials and an Accredited Professional Statistician, PStat®.

Current Research Interests

Data Access and Transparency
Pragmatic Clinical Trials
Clinical Trial Design
Data Monitoring Committees
Safety and Pharmacovigilance

Current Appointments & Affiliations

Contact Information

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.